Current & Emerging Neurologic Treatments?

SING24 sing24 at aol.com
Sun Apr 30 21:15:23 EST 1995


Regeneron (OTC-REGN) is a leading public company doing nerve growth
research on partnership with Amgen. Get their annual report. I have
neuropathy and live in the DC area and would be interested in the reasons
you are researching these issues and how your work has progressed.



More information about the Neur-sci mailing list